Total Current Liabilities - AVROBIO Inc (NASDAQ:TECX) - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 19.14 USD 0.74%
Market Cap: 281.9m USD
Have any thoughts about
AVROBIO Inc?
Write Note

AVROBIO Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AVROBIO Inc
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
AVROBIO Inc
NASDAQ:TECX
Total Current Liabilities
$6.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$41.9B
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$10.8B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$21.5B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$3.5B
CAGR 3-Years
25%
CAGR 5-Years
23%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.5B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
26%

See Also

What is AVROBIO Inc's Total Current Liabilities?
Total Current Liabilities
6.4m USD

Based on the financial report for Dec 31, 2023, AVROBIO Inc's Total Current Liabilities amounts to 6.4m USD.

What is AVROBIO Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 1Y
-52%

Over the last year, the Total Current Liabilities growth was -52%.

Back to Top